Spinal and Bulbar Muscular Atrophy

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AnnJi Pharmaceutical
AnnJi PharmaceuticalTaiwan - Taipei City
1 program
1
AJ201Phase 1/21 trial
Active Trials
NCT05517603CompletedEst. Apr 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
AnnJi PharmaceuticalAJ201

Clinical Trials (1)

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients

Start: Feb 2023Est. completion: Apr 2024
Phase 1/2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space